Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma

Bo Sung Yoon, YoungTae Kim, Sunghoon Kim, Chong Seung Lee, Jae Wook Kim, Jae-Hoon Kim, Sang Wun Kim, Namhoon Cho

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: To investigate the correlation of DNA ploidy, S-phase fraction (SPF) and the expression of cyclin A to the clinical prognostic factors in patients with epithelial ovarian cancer. Study design: A prospective analysis was performed on 46 ovarian tumor patients. The DNA ploidy and SPF were determined by flow cytometry and the expression of cyclin A was measured by immunohistochemical staining. Results: Compared with benign and borderline tumors, the malignant tumors expressed higher levels of cyclin A (P = 0.007), more aneuploid cells (P = 0.018) and higher SPF (P = 0.015). With regard to DNA ploidy and the clinical prognostic factors, aneuploid cells increased with tumor grade (P = 0.011), the disease stage (P = 0.009) and residual volume (P = 0.001). When residual tumor was more than 2 cm, the expression of cyclin A was increased (P = 0.043). Three-year survival was low for patients with tumors expressing cyclin A in over 10% of cells (P = 0.003). Conclusions: The data suggest that the assessment of the DNA ploidy, SPF and the expression of cyclin A may provide important information for predicting the prognosis of epithelial ovarian cancer.

Original languageEnglish
Pages (from-to)110-115
Number of pages6
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Volume136
Issue number1
DOIs
Publication statusPublished - 2008 Jan 1

Fingerprint

Cyclin A
Ploidies
Carcinoma
S Phase
DNA
Aneuploidy
Neoplasms
Residual Volume
Residual Neoplasm
Flow Cytometry
Staining and Labeling
Survival

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

@article{57c3ada449874b3888ac5d6b05ce184a,
title = "Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma",
abstract = "Objective: To investigate the correlation of DNA ploidy, S-phase fraction (SPF) and the expression of cyclin A to the clinical prognostic factors in patients with epithelial ovarian cancer. Study design: A prospective analysis was performed on 46 ovarian tumor patients. The DNA ploidy and SPF were determined by flow cytometry and the expression of cyclin A was measured by immunohistochemical staining. Results: Compared with benign and borderline tumors, the malignant tumors expressed higher levels of cyclin A (P = 0.007), more aneuploid cells (P = 0.018) and higher SPF (P = 0.015). With regard to DNA ploidy and the clinical prognostic factors, aneuploid cells increased with tumor grade (P = 0.011), the disease stage (P = 0.009) and residual volume (P = 0.001). When residual tumor was more than 2 cm, the expression of cyclin A was increased (P = 0.043). Three-year survival was low for patients with tumors expressing cyclin A in over 10{\%} of cells (P = 0.003). Conclusions: The data suggest that the assessment of the DNA ploidy, SPF and the expression of cyclin A may provide important information for predicting the prognosis of epithelial ovarian cancer.",
author = "Yoon, {Bo Sung} and YoungTae Kim and Sunghoon Kim and Lee, {Chong Seung} and Kim, {Jae Wook} and Jae-Hoon Kim and Kim, {Sang Wun} and Namhoon Cho",
year = "2008",
month = "1",
day = "1",
doi = "10.1016/j.ejogrb.2006.10.008",
language = "English",
volume = "136",
pages = "110--115",
journal = "European Journal of Obstetrics and Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma. / Yoon, Bo Sung; Kim, YoungTae; Kim, Sunghoon; Lee, Chong Seung; Kim, Jae Wook; Kim, Jae-Hoon; Kim, Sang Wun; Cho, Namhoon.

In: European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 136, No. 1, 01.01.2008, p. 110-115.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma

AU - Yoon, Bo Sung

AU - Kim, YoungTae

AU - Kim, Sunghoon

AU - Lee, Chong Seung

AU - Kim, Jae Wook

AU - Kim, Jae-Hoon

AU - Kim, Sang Wun

AU - Cho, Namhoon

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Objective: To investigate the correlation of DNA ploidy, S-phase fraction (SPF) and the expression of cyclin A to the clinical prognostic factors in patients with epithelial ovarian cancer. Study design: A prospective analysis was performed on 46 ovarian tumor patients. The DNA ploidy and SPF were determined by flow cytometry and the expression of cyclin A was measured by immunohistochemical staining. Results: Compared with benign and borderline tumors, the malignant tumors expressed higher levels of cyclin A (P = 0.007), more aneuploid cells (P = 0.018) and higher SPF (P = 0.015). With regard to DNA ploidy and the clinical prognostic factors, aneuploid cells increased with tumor grade (P = 0.011), the disease stage (P = 0.009) and residual volume (P = 0.001). When residual tumor was more than 2 cm, the expression of cyclin A was increased (P = 0.043). Three-year survival was low for patients with tumors expressing cyclin A in over 10% of cells (P = 0.003). Conclusions: The data suggest that the assessment of the DNA ploidy, SPF and the expression of cyclin A may provide important information for predicting the prognosis of epithelial ovarian cancer.

AB - Objective: To investigate the correlation of DNA ploidy, S-phase fraction (SPF) and the expression of cyclin A to the clinical prognostic factors in patients with epithelial ovarian cancer. Study design: A prospective analysis was performed on 46 ovarian tumor patients. The DNA ploidy and SPF were determined by flow cytometry and the expression of cyclin A was measured by immunohistochemical staining. Results: Compared with benign and borderline tumors, the malignant tumors expressed higher levels of cyclin A (P = 0.007), more aneuploid cells (P = 0.018) and higher SPF (P = 0.015). With regard to DNA ploidy and the clinical prognostic factors, aneuploid cells increased with tumor grade (P = 0.011), the disease stage (P = 0.009) and residual volume (P = 0.001). When residual tumor was more than 2 cm, the expression of cyclin A was increased (P = 0.043). Three-year survival was low for patients with tumors expressing cyclin A in over 10% of cells (P = 0.003). Conclusions: The data suggest that the assessment of the DNA ploidy, SPF and the expression of cyclin A may provide important information for predicting the prognosis of epithelial ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=37549035944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549035944&partnerID=8YFLogxK

U2 - 10.1016/j.ejogrb.2006.10.008

DO - 10.1016/j.ejogrb.2006.10.008

M3 - Article

VL - 136

SP - 110

EP - 115

JO - European Journal of Obstetrics and Gynecology and Reproductive Biology

JF - European Journal of Obstetrics and Gynecology and Reproductive Biology

SN - 0028-2243

IS - 1

ER -